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Abstract
The architecture of dendritic arbors determines circuit connectivity, receptive fields, and computational properties of
neurons, and dendritic structure is impaired in several psychiatric disorders. While apical and basal dendritic compartments
of pyramidal neurons are functionally specialized and differentially regulated, little is known about mechanisms that
selectively maintain basal dendrites. Here we identified a role for the Ras/Epac2 pathway in maintaining basal dendrite
complexity of cortical neurons. Epac2 is a guanine nucleotide exchange factor (GEF) for the Ras-like small GTPase Rap, and it
is highly enriched in the adult mouse brain. We found that in vivo Epac2 knockdown in layer 2/3 cortical neurons via in
utero electroporation reduced basal dendritic architecture, and that Epac2 knockdown in mature cortical neurons in vitro
mimicked this effect. Overexpression of an Epac2 rare coding variant, found in human subjects diagnosed with autism, also
impaired basal dendritic morphology. This mutation disrupted Epac2’s interaction with Ras, and inhibition of Ras selectively
interfered with basal dendrite maintenance. Finally, we observed that components of the Ras/Epac2/Rap pathway exhibited
differential abundance in the basal versus apical dendritic compartments. These findings define a role for Epac2 in enabling
crosstalk between Ras and Rap signaling in maintaining basal dendrite complexity, and exemplify how rare coding variants,
in addition to their disease relevance, can provide insight into cellular mechanisms relevant for brain connectivity.
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Introduction
Dendritic structure is critical for neuronal function, as the size
and shape of the dendritic arbor defines the neuron’s receptive
field [1]. Generating and maintaining proper arborization is
therefore crucial for neural circuit function [2]. The importance of
maintaining dendritic arborization is illustrated by observations of
loss of dendritic complexity in patients with neuropsychiatric
disorders. Reduced dendritic arborization occurs in patients with
psychiatric disorders with delayed onset, including schizophrenia
[3], as well as in autism spectrum disorders [4,5], and disorders
comorbid with autism, such as Rett [6] and Down syndromes [7–
9]. Thus, the maintenance of dendritic arbor complexity for
extended periods of time during development and into adulthood
is likely to be crucial for the preservation of functional circuitry
and connectivity relevant for learning and complex behaviors.
Patterns of dendritic branching are integral to the computa-
tional ability of the neuron [10,11]. An increasing body of
evidence suggests that the apical versus basal regions of the den-
dritic arbor are functionally specialized. These distinct dendritic
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and are selectively regulated in physiological and pathological
conditions [12,13]. Recent work probing the subcellular location
of thalamocortical and intracortical connections has revealed tight
spatial restriction of synapses to various somatic and dendritic
compartments. Laminar positioning of target cells in the cortex
and afferent cell type are critical determinants of synaptic
positioning along the dendritic arbor. For example, ascending
inputs target basal dendrites in layer 2/3 [13]. Basal dendrites are
also the target of substantial inhibitory innervation by interneu-
rons, allowing for the tight regulation of excitability [14]. From a
computational perspective, even very small basal dendrites are
capable of large effects on cell output [12]. Thus, subtle
morphological alterations to the basal dendritic arbor may have
large consequences for cellular and circuit function.
Consistent with the selective function of dendritic compart-
ments, there is evidence for the selective regulation and
maintenance of apical versus basal dendritic compartments.
Environmental enrichment appears to have region- and cell-
specific effects on dendrites, but preferentially enhances basal
arborization [15,16], and sensory deprivation during a critical
developmental period can prevent normal basal dendritic elabo-
ration in the barrel cortex of rats [17]. While a few molecular
alterations selectively affect distinct dendritic compartments,
including PTEN or dopamine receptor D1 loss [18,19], the
molecular mechanisms that specifically govern basal dendrite
maintenance in cortical neurons remain unclear.
Regulators of Ras-like small GTPases have been extensively
implicated in neuronal morphogenesis [20]. The EPAC2 gene
encodes Epac2 (exchange protein directly activated by cyclic AMP
2), a guanine nucleotide exchange factor (GEF) for the Ras-like
small GTPase Rap, which is highly enriched in the adult brain
[21] and dendrites [22]. Previous studies utilizing an Epac-specific
agonist have found that Epac activation can modulate synaptic
plasticity [23] as well as memory retrieval in mice [24], and EPAC
null mice exhibit deficits in spatial reference memory and social
interactions [25], implicating Epac in brain function. Epac2 has
been implicated in the outgrowth of neuronal processes in vitro
[26,27], but its role in dendritic morphogenesis within the cortex is
not known. In the present study we observed that Epac2
knockdown robustly and selectively impaired basal dendrite
maintenance in cortical pyramidal neurons in vivo and in culture.
Recent genetic studies have detected numerous rare coding
mutations in subjects with neurodevelopmental disorders [28].
While their significance for disease etiology remains to be
elucidated, such mutations might provide insight into a protein’s
functional role in important cellular processes. Previously, four
rare amino acid coding variants had been identified in EPAC2 in
subjects with autism [29]. In the present study we observed that
expressing one of these rare coding variants robustly and
selectively reduced basal dendrite complexity in cortical pyramidal
neurons and impaired Epac2’s interaction with Ras. The use of a
disease-associated point mutation as a method of probing
molecular function revealed that Epac2 mediates crosstalk
between Ras and Rap to specifically regulate basal dendritic
complexity in cortical neurons. This approach exemplifies a more
general ‘‘reverse translational’’ strategy for discovery of basic
cellular mechanisms.
Results
Epac2 Is Selectively Required for the Maintenance of
Basal Dendrite Complexity In Vivo
Epac2, an upstream regulator of Rap activity, is involved in
regulating synapse morphology [22], but its role in regulating the
architecture of the dendritic tree in cortical neurons is unknown.
We first tested whether altered expression of Epac2 affected the
maintenance of dendritic arbors in vivo, using in utero electro-
poration (IUEP) [30] to knock down protein expression (Figure
S1A). Using a previously characterized RNA interference (RNAi)
construct selective for Epac2 [22], we coinjected either Epac2-
RNAi, or control (pGSuper), with pCAG-eGFP into the subven-
tricular zone of E16.5 mouse embryos to specifically target layer
2/3 neurons. Electroporated constructs were allowed to express
until brain harvesting and sectioning on postnatal day 28 (P28). In
vivo knockdown of the Epac2 protein via Epac2-RNAi was
confirmed at P28 by immunohistochemistry of cortical sections.
Quantification of GFP-positive cells revealed that Epac2 was
knocked down by ,75% compared to GFP-negative cells (Figure
S1B–C). Electroporated neurons were specifically found in layer
2/3 (Figure 1A). When we analyzed dendritic morphology by
measuring apical and basal dendritic number and length in GFP-
positive cells, we observed that long-term knockdown of Epac2
expression specifically reduced basal dendrites. Examination of
basal arbors of layer 2/3 neurons from P28 mice expressing GFP
and Epac2-RNAi (Figure 1B–F) revealed a ,42% reduction in
basal dendritic branches and a ,54% reduction in basal dendritic
length (p,0.001; Figure 1E–F) compared to cells from P28 mice
expressing GFP and control construct. This effect on basal
dendritic morphology was mediated by a ,30% reduction in
secondary and a ,65% reduction in tertiary order basal branch
number (p,0.05, 0.001; Figure 1G, Table S1A). Additionally,
basal dendritic length was reduced by ,24% in secondary
branches and ,55% in tertiary branches (p,0.05, 0.001;
Figure 1H, Table S1B). The effect of Epac2 knockdown from
E16.5 to P28 was specific for basal dendritic arbors, as Epac2-
RNAi had no effect on apical dendrite branch number or length in
these cells (Figure 1E–H, Table S1A–B).
To eliminate the possibility of inter-individual and reporter
expression variability, we took advantage of the sparse nature of
IUEP gene transfer to directly compare dendritic morphology
between neighboring non-Epac2-RNAi-expressing cells versus
Author Summary
A fundamental feature of a neuron is the morphology of its
dendrites, which are the processes that receive and
integrate synaptic signals from other neurons. Neurons
in the mammalian cortex exhibit two distinct dendritic
arbors: apical dendrites, which extend far from the cell
body, and basal dendrites, which elaborate locally around
the cell body. After development, neurons must actively
maintain each of these dendritic arbors to sustain their
specific connectivity. Because several neurological and
neurodevelopmental disorders are associated with disrup-
tions in dendritic morphology, it is crucial to understand
the molecular mechanisms that regulate the process of
active maintenance of dendritic arbors. We find that
disruption of a particular molecular pathway, the Ras-
Epac2 pathway, can result in dramatic simplification of
basal, but not apical, dendritic arbors in both cultured
neurons and in the intact mouse brain. We show that a
mutant form of Epac2, identified in patients with autism,
also impairs basal dendrite maintenance and disrupts its
interaction with Ras. Our findings suggest that specific
molecular pathways can regulate distinct dendritic regions,
and that disease-related mutations can inform our under-
standing of the molecules that regulate important biolog-
ical processes.
Epac2 Autism Mutation Affects Basal Dendrites
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region from the same mice. Epac2-RNAi-expressing cells could be
easily identified by the coexpression of pCAG-eGFP, while
neighboring control cells not expressing Epac2-RNAi were
identified by the lack of GFP expression. Pairs of GFP- and
non-GFP-expressing neurons were filled with biocytin and stained
with streptavidin-568 conjugated fluorescent probe to visualize
dendritic morphology (Figure 2A). Using 2-photon laser scanning
microscopy, we imaged paired layer 2/3 cells in the anterior
frontal cortex, an area previously described to display abnormal
circuitry in disease-related animal models [31]. Cortical slices were
cut at a thickness of 300 mm to allow reconstruction of the
majority of the apical and basal dendritic fields of these cells. This
approach further confirmed that loss of Epac2 resulted in a specific
reduction of basal dendrite complexity: Epac2-RNAi-expressing
cells displayed an overall decrease in basal dendritic branch
number (,47%) and basal dendritic length (,53%) (p,0.05, 0.01;
Figures 2B–C, S2A–B). Furthermore, Epac2-RNAi-expressing
cells had ,30% fewer basal secondary dendrites and ,55%
fewer basal tertiary dendrites (p,0.05, 0.001; Figure 2D–E, Table
S2). In addition, secondary basal length was reduced by ,25%
and tertiary basal length was reduced by ,32% in Epac2-RNAi-
expressing cells (p,0.05, 0.001; Figure 2D,F, Table S3). This
effect was driven by the absence of high order branches (tertiary
branches and beyond; Figure 2D–F). No effect on apical dendrite
complexity (Figure S2C, Table S2) or length (Figure S2D, Table
S3) was observed. Together, these data demonstrate that Epac2
signaling is required for maintaining higher order branching of
basal dendrites in vivo. Interestingly, extended Epac2 knockdown
in vivo also reduced dendritic spine density on both apical and
basal dendrites, as compared to paired control electroporated cells
(Figure S2E–G). This effect contrasted with that of acute (5-d)
Epac2 knockdown in vitro [22], which did not alter dendritic spine
numbers, but suggests that prolonged reductions in Epac2
signaling can have pronounced effects on basal dendrites and
more subtle effects on apical dendrites.
Knockdown of Epac2 Impairs Basal Dendrite
Maintenance in Cultured Neurons
Epac2 knockdown by in utero electroporation reduced Epac2
expression throughout development; however, it is not clear when
Epac2 expression is required for normal dendritic morphology. To
directly test the role of Epac2 in dendritic maintenance, we used
an RNAi approach in mature cultured neurons, allowing
perturbations in Epac2 expression levels after the dendritic arbor
has already been established. This system has also been extensively
used for mechanistic studies of structural plasticity [22,32–34] and
allows examination of the potential molecular underpinnings of
dendritic architecture. A number of studies have demonstrated
that mature cultured pyramidal neurons develop pyramidal
morphologies with primary (classified as ‘‘apical’’) and non-
primary (classified as ‘‘basal’’) dendrites that resemble morphol-
ogies observed in vivo (see Materials and Methods for description
of criteria used for identifying apical and basal dendrites of
cultured neurons) [34–36]. We knocked down Epac2 expression in
mature (DIV 23–28) cultured cortical neurons (Figure 3A), and
used Sholl analysis [37] as well as dendritic length measurements
to assess the complexity and morphology of basal or apical
dendritic compartments (Figure S3A–D). Consistent with our in
vivo data, reduced Epac2 expression selectively decreased
dendritic complexity in an asymmetric manner. Epac2 knockdown
reduced basal dendritic intersections 25–175 mm from the soma,
as well as basal dendrite length, without affecting apical dendrite
length or complexity (basal dendritic length: length (mm), control:
9566164; Epac2-RNAi: 2736100; rescue: 6476124, p,0.005;
Figure 3B–C). Importantly, this deficit was rescued by overex-
pressing an RNAi-resistant mutant of Epac2 (‘‘Epac2-rescue’’)
[22]. Epac2-rescue overexpression did not significantly alter basal
or apical complexity compared to control, but significantly
increased basal complexity 25–100 mm from the cell body and
basal dendrite length compared to Epac2-RNAi (Figure 3B–C).
Similar to the effect of Epac2 knockdown in in utero electropo-
rated neurons, Epac2 expression levels were reduced down by
similar degrees (,75%) in both apical and basal dendritic
compartments in cultured cells overexpressing Epac2-RNAi
(Figure S3E). Given that Epac2 knockdown occurred in mature
neurons after their dendritic arbors had been established, these
data suggest that Epac2 plays a role in maintenance of the basal
dendritic arbor.
Differential Regulation of Dendritic Compartments by a
Disease-Associated Variant
Rare protein-coding variants of the EPAC2 gene have
previously been identified in several subjects with autism [29].
One of these missense mutations (Epac2-G706R), detected in four
human subjects with autism from two families, is located within
the Ras association (RA) domain of Epac2 (Figure 4A), suggesting
that it may affect one of Epac2’s functional domains. To
investigate the effect of this mutation on neuronal morphology,
we expressed either Epac2-G706R or its wildtype counterpart in
cultured cortical neurons. Expression of Epac2-G706R (Figure 4B),
followed by Sholl analysis, revealed a robust selective decrease in
basal dendrite complexity 50–100 mm from the soma, compared
to Epac2-WT, with no effect on apical dendrites (Figure 4C).
Furthermore, overexpression of Epac2-G706R reduced basal
dendrite length relative to Epac2-WT (p,0.05; Figure 4D), but
did not affect apical dendritic length (Figure 4D). We have
previously shown that overexpression of Epac2-G706R in neurons
does not affect basal Rap-GEF activity or dendritic spine
morphology [22]. Comparison of the effects of Epac2-G706R
overexpression to GFP alone revealed a decrease in basal
complexity 25–50 mm from the soma, but no change in apical
complexity, basal length, or apical length (Figure S4A–C),
suggesting that Epac2-G706R is a loss-of-function mutation.
Taken together, these data suggest that Epac2-G706R, a variant
that occurs in human patients, specifically alters basal dendrite
maintenance, without affecting apical dendritic structure, synaptic
morphology, or baseline Rap activation levels.
Figure 1. Epac2 regulates basal dendrite complexity in vivo. (A) Low magnification images of in utero electroporated layer 2/3 cortical
neurons, expressing either control or Epac2-RNAi. Animals were electroporated at E16.5; coronal slices (50 mm) were made at P28. Red dashed
rectangles indicate images represented in (B–D). (B) High magnification images of layer 2/3 cortical neurons outlined in (A). (C–D) Binary images (C)
and ‘‘skeleton outline’’ of basal and apical arbors (D), separated into primary, secondary, and tertiary branches, of neurons shown in (B). (E)
Quantification of dendrite numbers separated into total apical and basal dendrite branches. Epac2 knockdown in vivo induced a loss of basal
dendrites. (F) Epac2 knockdown in vivo induced a selective reduction in basal dendrite length. (G) Quantification of dendrite branch numbers
separated into basal/apical, primary/secondary/tertiary order branches. Epac2 knockdown in vivo induced a loss of basal dendrites, specifically driven
by a loss of secondary and tertiary basal dendrites. (H) Epac2 knockdown in vivo selectively reduced secondary and tertiary basal dendrite lengths.
*p,0.05, ***p,0.001; scale bars, 100 mm (A); 50 mm (B–D).
doi:10.1371/journal.pbio.1001350.g001
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mutation in the Epac2 protein might offer insight into the
mechanisms of asymmetric maintenance of dendritic compart-
ments. The small GTPase Ras and its signaling partners have been
implicated in neuronal morphogenesis [20,38–42]. Given that the
G706R mutation is within Epac2’s Ras-association (RA) domain
(Figure 4A), we hypothesized that this mutation might alter
Epac2’s interaction with Ras and that abnormal association with
Ras could underlie the dendritic effects induced by Epac2-G706R.
Epac2 has been shown to interact with Ras in non-neuronal cells
[43], but this interaction has not yet been established in cortical
neurons. We therefore tested whether Epac2 interacted with Ras
in rat cortical neurons by coimmunoprecipitation. We found that
Ras coimmunoprecipitated with Epac2 in mature cortical neurons
(DIV 25) (Figure 4E). This interaction was dependent on the
activation state of Ras: Ras activation by incubation with GTPcS
enhanced the interaction between Ras and Epac2, whereas Ras
inhibition by treatment with GDP reduced the interaction
(p,0.05, 0.001; Figure 4F). This interaction was further confirmed
by ectopic expression of HA-tagged Epac2-WT alone or with
YFP-Ras in hEK293 cells (Figure S4D). We then tested the ability
of Epac2-G706R to interact with Ras by coexpressing YFP-Ras
with HA-Epac2-WT or HA-Epac2-G706R in hEK293 cells, and
immunoprecipitating with YFP-Ras (Figure 4G). Indeed, quanti-
tative analysis of coimmunoprecipitation revealed that Epac2-
G706R displayed significantly impaired Ras interaction (p,0.001;
Figure 4H). These results demonstrate that a naturally occurring
Epac2 variant specifically alters basal dendritic architecture, and
that interaction with Ras may be a key feature of Epac2’s role in
regulating basal dendritic maintenance.
Ras Signaling Controls Basal Dendrite Complexity
The findings that Epac2 is required for the maintenance of basal
(non-primary) dendrites, and that a rare coding variant that
specifically disrupts Epac2’s interaction with Ras mimics this
selective morphological phenotype but has no affect on Epac2’s
basal Rap-GEF function [22], suggest a role for Epac2 and Ras
signaling in the maintenance of basal dendrite complexity. Ras is a
small GTPase that has been strongly linked to structural plasticity
in neurons [20,39–42,44,45], but its specific role in the mainte-
nance of basal dendrite complexity in mature neurons has not
been directly tested.
Thus, we tested whether disruption of endogenous Ras activity
by the farnesyl transferase inhibitor II (FTaseII) could affect either
apical or basal dendrite maintenance. We used time-lapse imaging
of live mature (DIV 25) cultured cortical pyramidal neurons,
expressing GFP and treated with either vehicle or FTaseII
(200 nM) and measured dendritic complexity and length before
and after treatment (Figure 5A and S5A). Imaging of neurons for
2 h prior to treatment revealed a remarkable stability of the
dendritic arbor (Figure 5A–E) with an almost equal gain and loss
of apical and basal dendrites. Imaging of apical and basal
dendrites for 6 h following vehicle treatment did not reveal any
changes in basal or apical dendrite complexity or length
(Figure 5A–E). In contrast, incubation with FTaseII resulted in a
robust retraction of basal dendrites over 6 h, as demonstrated by a
reduction of basal complexity (normalized basal dendrite inter-
sections: 0 h: 1.0460.03 versus 0.9560.05; 6 h 1.0260.5 versus
0.5660.08; control versus FTaseII, p,0.001; Figure 5A–B), and a
loss of dendritic length (normalized basal dendrite length: 0 h:
1.0660.02 versus 1.0160.04; 6 h: 1.0260.4 versus 0.5460.06;
control versus FTaseII, p,0.001; Figure 5A,C). This loss of length,
driven by a progressive retraction of basal dendrites, was not seen
in vehicle-treated neurons (Figure 5D–E). There was no change in
apical dendrites (Figure 5B–C).
We further confirmed these results in neurons fixed following
treatment with FTaseII or vehicle for 6 h (Figure S5B–D). Sholl
analysis revealed that FTaseII treatment specifically reduced basal
complexity 25–100 mm from the soma (Figure S5C) and basal
dendritic length (basal dendrite length (mm); control, 1,4056221;
FTaseII, 6026155, p,0.05; Figure S3D) with no effect on apical
dendrite complexity or length (Figure S5C–D). The very specific
effect of short-term FTaseII treatment on the dendritic tree is
quantitatively similar to that of Epac2 knockdown or Epac2-
G706R overexpression (which displays impaired Ras binding),
suggesting that interference with Ras signaling, but not other
potential targets of FTaseII, in cortical neurons results in a
selective reduction of basal complexity.
To further investigate the impact of interference with Ras
signaling on dendritic architecture, we mimicked Ras inhibition by
expression of a dominant-negative Ras mutant (Ras S17N;
RasDN). Expression of RasDN alone (Figure S5E–F), followed
by Sholl analysis, revealed a robust selective decrease in basal
dendrite complexity 50–100 mm from the soma, compared to GFP
(control), with no effect on apical arbors (Figure S5F), paralleling
the effects seen following short-term FTaseII treatment. Further-
more, overexpression of RasDN reduced basal dendrite length
relative to control (basal dendrite length (mm); GFP, 1,7046122;
RasDN, 9876198, RasDN+Epac2-WT 1,5196160, p,0.05;
Figure S5E–F), but did not affect apical dendritic length (Figure
S5G). Importantly, co-expression of Epac2-WT was sufficient to
rescue RasDN-induced loss of basal dendrites and basal dendritic
length (Figure S5E–G). These data provide further support for the
role of the Ras/Epac2 pathway in the maintenance of basal, but
not apical, dendrites.
Asymmetric Distribution of the Ras/Epac2/Rap Pathway
Across the Dendritic Arbor
The distribution of the Ras, Epac2, and Rap proteins across the
dendritic tree of cortical neurons has not yet been examined. We
thus compared the relative amounts of Epac2, Ras, and Rap
immunostaining intensity in basal versus apical dendrites of
cortical neurons in culture. All intensity measurements were
limited to secondary apical or basal dendrites and were normalized
to unit area (mm
2) to ensure that measurements of protein content
between apical and basal dendrites of different thicknesses were
comparable (Figure 6). We observed more intense labeling for
each protein in apical dendrites than in basal dendrites (p,0.05,
Figure 2. Comparison of paired cell morphology following in vivo knockdown of Epac2 by in utero electroporation reveals reduced
basal arbors of layer 2/3 cortical neurons. (A) Left, image of paired cells, one positive for Epac2-RNAi, filled with biocytin and imaged by 2PLSM
in 300 mm-thick cortical slices. Right, binary images of biocytin-filled paired layer 2/3 neurons to the left. Animals were electroporated at E16.5;
cortical slices (300 mm) were made at P28. (B) Quantification of total dendrite numbers separated into apical and basal dendrite branches. Epac2
knockdown in vivo induced a loss of basal dendrites compared to paired control cells. (C) Epac2 knockdown in vivo selectively reduced basal dendrite
length when compared to paired control cells. (D) ‘‘Skeleton outline’’ of basal and apical arbors, separated into primary, secondary, and tertiary
branches, of neurons shown in (A). (E) Quantification of basal dendrite numbers reveals that Epac2 knockdown in vivo induces a loss of higher order
branches compared to paired control; blue square, control; red circles, Epac2-RNAi; black squares with error bars, mean, SEM. (F) Analysis of basal
dendrite length demonstrates a selective reduction in higher order basal length. *p,0.05, **p,0.01, ***p,0.001; scale bars, 50 mm.
doi:10.1371/journal.pbio.1001350.g002
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phosphorylated (active) BRaf (p-BRaf), a direct target of both
Ras and Rap small GTPases [20,22]. As with Ras, Epac2, and
Rap, we found that p-BRaf was more abundant in apical dendrites
than in basal dendrites (p,0.001; Figure 6G–H). Interestingly the
same subcellular distribution was observed for overexpressed
Epac2-WT and Epac2-G706R (p,0.01; Figure S6A–B). Epac2-
G706R signal was reduced compared to that of Epac2-WT in
basal dendrites, but not apical dendrites, in these cells (p,0.05;
Figure S6C). In order to determine whether this asymmetric
pattern was specific for Ras/Epac2/Rap pathway, we also
examined the distribution of kalirin-7, a GEF for the small
GTPase Rac, and the phosphorylated (active) form of p21-
activated kinase (p-PAK), a direct downstream effector of Rac
[46]. In contrast with the above findings, kalirin-7 and p-PAK
immunofluorescence was equally distributed across apical and
Figure 3. Epac2 is required for selective maintenance of basal dendrite complexity and length. (A) Binary images of cultured cortical
neurons (DIV 23–28) expressing GFP, GFP+Epac2-RNAi, or GFP+Epac2-RNAi+Epac2-rescue. (B) Epac2-RNAi selectively reduces complexity of basal
arbors. Expression of RNAi-insensitive Epac2-rescue recovers Epac2-RNAi-induced reduction of basal dendrite complexity to control levels. (C) Epac2-
RNAi reduces basal dendritic length, while Epac2-rescue prevents this effect. {, difference between Epac2-rescue and Epac2-RNAi, p,0.05, *p,0.05,
**p,0.01, ***p,0.001; scale bars, 100 mm.
doi:10.1371/journal.pbio.1001350.g003
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distribution of Ras/Epac2/Rap was specific to this pathway.
Because we observed asymmetry in the levels of Epac2/Ras/
Rap across dendritic compartments of cortical neurons, we
wondered if perturbations of this pathway might lead to
differential signaling output in basal versus apical dendrites. To
address this question, we specifically inhibited Ras signaling or
reduced Epac2 expression by RNAi throughout the neurons, and
examined p-BRaf immunofluorescence in individual dendritic
compartments. Inhibition of Ras using FTaseII (Figures 7A, S7A)
resulted in a ,22% reduction in p-BRaf levels in apical dendrites
compared to control (Figures 7A–C, S7A), but produced a more
profound reduction in p-BRaf levels in basal dendrites (,45%
compared to control basal levels), which was significantly different
to both control and FTaseII-induced apical p-BRaf levels (mean p-
BRaf intensities relative to control levels: FTaseII; apical
0.7660.04; basal 0.5560.01; p,0.001; Figures 7B–C, S7B–C).
Examination of endogenous Epac2 levels in control (pGSuper) and
Epac2-RNAi cells revealed that Epac2 expression was less
abundant in basal dendrites than apical dendrites after Epac2
knockdown (reduced by ,37% compared to apical levels; Figure
S7D), suggesting that asymmetric localization of Epac2 is
maintained under knockdown conditions. Moreover, comparison
of Epac2 immunofluorescence in apical or basal compartments in
control versus Epac2-RNAi-expressing neurons, relative to Epac2
levels in control apical dendrites, revealed that Epac2 expression in
apical dendrites of Epac2-RNAi cells was not significantly different
from Epac2 levels in control basal dendrites (Figure S7E),
suggesting that apical dendrites may contain enough Epac2 even
in the knockdown condition to preserve apical dendrite morphol-
ogy. Epac2 knockdown (Figures 7D, S7F) resulted in a greater
reduction of p-BRaf levels in basal dendrites (,47%) versus apical
dendrites (,20%), when compared to control levels (mean p-BRaf
intensities relative to control levels: Epac2-RNAi; apical
0.8060.07; basal 0.5260.04; p,0.001; Figures 7D–F, S7F–H).
Collectively, these data suggest that the signaling output of the
Ras/Epac2/Rap pathway is asymmetric across dendritic com-
partments of cortical neurons.
Figure 4. Disruption of Epac2 interaction with Ras by point mutation impairs basal dendritic maintenance. (A) Domain structure of
Epac2: cAMP-binding (cAMP); domain found in Dishevelled, Egl-10, and Pleckstrin (DEP); N-terminus of Ras-exchanger motif (REM); Ras-association
(RA); Rap-Guanine Exchange Factor (Rap-GEF). Asterisk indicates position of Epac2-G706R rare variant. (B) Representative binary images of cortical
neurons expressing GFP+Epac2-WT or GFP+Epac2-G706R. (C) Sholl analysis of apical and basal dendrites reveals a significant decrease in basal
complexity in Epac2-G706R-expressing cells. (D) Quantification of apical and basal dendrite length. (E) Ras activation by GTPcs results in stronger
coimmunoprecipitation of Epac2 with Ras in neurons, while inactivation of Ras by GDP reduces Ras-Epac2 interaction. (F) Quantification of (E). (G)
Epac2-G706R point mutation exhibits impaired interaction with Ras in hEK293 cells. (H) Quantification of G. *p,0.05, **p,0.01, ***p,0.001; scale bar,
100 mm.
doi:10.1371/journal.pbio.1001350.g004
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PLoS Biology | www.plosbiology.org 8 June 2012 | Volume 10 | Issue 6 | e1001350Figure 5. Ras inhibition induces basal dendrite retraction. (A) Binary image of basal dendrites of live-imaged cells at time points 22, 0, and
6 h of FTaseII (200 nM) or vehicle treatment. Cyan lines indicate newly formed dendrites; red lines indicate eliminated dendrites. Under control
conditions, loss and gain of dendrites remains constant over imaging period. Treatment with FTaseII results in a dramatic loss of basal dendrites after
6 h of treatment. (B–C) Quantification of apical and basal arbor complexity (B) and apical and basal dendritic length (C). Data are normalized to 22h
time point. *, difference between control and FTaseII condition; #, difference between time points. (D–E) Frame-by-frame montage of basal dendrite
stability under control (vehicle-treated) conditions (D; white arrows indicate stable dendrites), or of basal dendrite retraction following FTaseII
treatment (E; red arrows indicate retracting basal dendrite). #, ***p,0.001; scale bars, 100 mm (A), 10 mm (D, E).
doi:10.1371/journal.pbio.1001350.g005
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PLoS Biology | www.plosbiology.org 9 June 2012 | Volume 10 | Issue 6 | e1001350Figure 6. Asymmetric distribution of Ras/Epac2/Rap/p-BRaf in cortical neuron dendrites. (A) Distribution of Epac2 in apical and basal
dendrites. Endogenous MAP2 indicates dendrites. (B) Epac2 fluorescence intensity (normalized to unit area, mm
2, and indicated by pseudocoloring) is
reduced in secondary basal dendrites. (C–F) Analysis of Ras (C–D) or Rap (E–F) distribution revealed that Ras and Rap are asymmetrically distributed
over apical and basal dendrites. GFP outlines dendrite morphology. (G) Distribution of phosphorylated (active) BRaf in apical and basal dendrites.
Endogenous MAP2 indicates dendrites. (H) p-BRaf levels are reduced in basal dendrites compared to apical dendrites. *p,0.05, **p,0.01,
***p,0.001; Scale bars, 35 mm (A, C, E, G), 5 mm (A, C, E, G insets).
doi:10.1371/journal.pbio.1001350.g006
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Here we showed that Epac2 is important for the selective
maintenance of basal dendrite complexity in cortical neurons.
Utilizing a rare coding variant of Epac2, found in human patients,
to probe the molecular and cellular functions of Epac2 in the
context of dendritic complexity of cortical pyramidal neurons, we
identified Ras as a signaling partner of Epac2 in this pathway. Our
findings support a model in which Epac2, as a Rap-GEF, enables
crosstalk between two morphogenic GTPase signaling pathways to
maintain basal dendrites.
The importance of maintaining dendritic architecture is
illustrated by observations of dendritic complexity in pathological
analysis of patients with neuropsychiatric and neurodevelopmental
disorders. Reduced dendritic arborization occurs in patients with
psychiatric disorders with delayed onset, including schizophrenia
[3], autism spectrum disorders [4,5], and disorders comorbid with
autism, such as Rett [6] and Down syndromes [7–9]. In Down
syndrome, loss of dendritic arbors occurs in a progressive manner:
prior to 2 y of age, dendritic hypertrophy was observed in the
cortex of subjects with Down syndrome; thereafter, dendritic
arbors were reduced in complexity relative to controls [7–9],
suggesting an initial period of dendritic overgrowth followed by a
later stage in which maintenance mechanisms are potentially
disrupted or lost. An early study of visual cortex from subjects with
Down syndrome revealed a selective loss of basal dendrite
complexity [47], though subsequent studies have also detected
apical deficits [8]. Rett syndrome, a monogenic disorder
frequently accompanied by an autistic phenotype, features
dendritic deficits, usually in basal dendrites and occasionally in
apical dendrites [6]. Individuals with autism exhibited reduced
dendrite numbers and dendritic cytochemical markers in the
cortex [4] and hippocampus [5]. Thus, a more complete
understanding of molecular mechanisms that contribute to the
maintenance of specific aspects of the dendritic arbor may hasten
the development of therapeutic strategies that aim to prevent the
apparent progressive loss of dendritic complexity and to preserve
functional cortical circuits in patients with neurodevelopmental
and neuropsychiatric disorders in which dendritic structure is
affected.
Several lines of evidence support the selective regulation of
apical versus basal dendritic compartments. Environmental
enrichment has been shown to selectively increase basal dendrite
length, while stress can reduce basal dendritic length, in layer 2/3
cells of the auditory cortex [15]. Sensory deprivation by whisker
trimming during a critical developmental window, between P9
and P15 in rats, delayed normal basal dendritic elaboration of
layer 2/3 pyramidal cells in the barrel cortex [17]. PTEN
knockout results in selective outgrowth of apical dendrites,
demonstrating that inhibition of mTOR blocks continued apical
but not basal dendrite growth under stable conditions in mature
animals [18]. Particularly relevant to Epac2 signaling is the recent
report that knockout of dopamine receptor D1 in mouse cortex
results in selective basal dendrite loss [19], as Epac2 is also
regulated by D1/cAMP signaling [22]. Given the ability of Epac2
to selectively regulate the basal arbor, signaling through Epac2
may be a key mechanism for control of select dendritic
compartments. A current hypothesis is that the establishment
and elaboration of apical and basal arbors occur at distinct time
points, with basal dendrites developing after apical dendrites, and
thus may involve distinct regulatory mechanisms [48]. Our
knockdown data indicate that Epac2 is required for the
maintenance of higher order basal dendrite branches. Elaboration
of higher order basal dendrite branching, which increases basal
dendrite complexity, occurs subsequent to the formation of the
primary proximal basal arbor and the apical arbor [48].
Interestingly, this time point (3 wk postnatal) coincides with a
dramatic increase in Epac2 expression in cortical neurons [22].
Thus, our findings support a role for Epac2 in regulating the
maintenance of basal dendritic complexity once these complex
arbors have been initially established.
Here we were guided by a rare coding mutation, naturally
occurring in human subjects with autism, to identify the Ras/
Epac2 interaction as important for the control of basal dendrite
complexity in cortical neurons. Interestingly, a different point
mutation in the RA domain of Epac2, identified through sequence
analysis rather than occurrence as a rare variant in human
patients, has also been shown to disrupt the interaction with Ras in
COS cells [49], suggesting that single-residue sites in this domain
of Epac2 may be crucial for its function in response to Ras, and
that even single amino acid mutations occurring as rare variants
may have functional or pathological consequences. Our strategy
exemplifies how mutations identified in humans with neurodevel-
opmental or psychiatric disorders, beyond their relevance for
disease, could provide functional insight into novel mechanisms
underlying brain development and connectivity. A growing
number of rare single amino acid mutations have been identified
in neuropsychiatric disorders by recent genetic studies, and with
the advent of whole exome or genome sequencing, their numbers
are expected to increase dramatically [50]. While their significance
for disease etiology remains to be elucidated, our approach taken
in this study shows that such mutations might help identify cellular
mechanisms that control crucial cellular processes, including
dendrite arborization. About 20% of single amino acid mutations
are thought to be damaging, with another 53% being mildly
deleterious [51]. Given that rare mutations are thought to make up
a significant fraction of the genetic architecture of complex
diseases, functional characterization of such mutations may
provide novel insight into both physiology and pathophysiology.
In this study, we show that a pathway involving Ras/Epac2/
Rap contributes to the maintenance of basal dendrite complexity.
The G706R point mutation disrupted the Ras-Epac2 interaction
and reduced basal complexity, and Ras inhibition experiments
using FTaseII or RasDN overexpression specifically affected basal
dendrite maintenance, suggesting that this pathway exerts specific
control over basal dendritic complexity in pyramidal neurons. Our
Figure 7. Asymmetric regulation of BRaf phosphorylation in cortical neuron dendrites. (A–C) Inhibition of Ras signaling by FTaseII
(30 min, 200 nM) reduced p-BRaf immunofluorescence in basal dendrites compared to apical dendrites. Yellow boxes in (A) indicate areas in high
magnification in (B). Endogenous MAP2 indicated dendrites. p-BRaf fluorescence intensity was normalized to unit area (mm
2) and is indicated by
pseudocoloring. White dashed lines outline dendrite. (C) Quantification of p-BRaf immunofluorescence in basal versus apical dendrites after 30 min
FTaseII treatment relative to control apical levels (dashed gray line). (D–F) Inhibition of Epac2 function by Epac2-RNAi resulted in selective and robust
reduction of p-BRaf immunofluorescence in basal dendrites compared to apical dendrites. Yellow dashed boxes in (D) indicate areas in high
magnification in (E). Overexpressed GFP outlined dendrite morphology. p-BRaf fluorescence intensity was normalized to unit area (mm
2) and is
indicated by pseudocoloring. White dashed lines outline dendrite. (F) Quantification of p-BRaf immunofluorescence in basal versus apical dendrites in
Epac2-RNAi-expressing cells relative to control apical levels (dashed gray line). **p,0.01, ***p,0.001 compared to control levels; #p,0.001
compared to apical p-BRaf levels after treatment (C, F); scale bars, 35 mm (A, D), 5 mm (B, E).
doi:10.1371/journal.pbio.1001350.g007
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signaling to dendrite maintenance in mature cortical neurons are
consistent with a number of previous findings. Dominant-negative
Rap1-expressing layer 5 pyramidal neurons exhibit deficits in
basal dendrite arborization during development [38]. In non-
neuronal cells, activated Ras has been shown to recruit Epac2 to
the plasma membrane, thereby activating membrane-associated
pools of Rap [43]. In adrenally derived PC12 cells, Ras activation
can recruit Epac2 to the plasma membrane, activate membrane-
associated pools of Rap1, and induce the outgrowth of neurite-like
structures [49]. Recent characterizations of EPAC null mice reveal
cognitive and behavioral phenotypes, illustrating the importance
of Epac in complex behavior and brain function [25]; however,
dendritic architecture of cortical neurons was not measured in this
mouse model. Our data implicating Epac2 in the maintenance of
basal arbors of cortical neurons provide a potential mechanism for
the disruption of neuronal circuitry upon perturbations of this
pathway. Our observation of asymmetric distribution of Epac2,
Ras, and Rap proteins is consistent with the selective effect of
reduced Ras/Epac2 signaling on the maintenance of basal
dendrites. Indeed, it is reasonable to expect that other redundant
mechanisms are employed for the active maintenance of apical
dendritic architecture, which may require more stability during
the life of the neuron. Our data showing that disruption of a single
pathway can alter basal maintenance are consistent with the
intrinsic dynamism of basal dendrites, due to the higher demands
for plasticity driven by sensory and inhibitory inputs to this
compartment [11,13,14]. Taken together, our data support a
model in which Epac2 couples with Ras signaling and actively
maintains basal dendrites in cortical pyramidal neurons.
Materials and Methods
Reagents
Farnesyl transferase inhibitor II was purchased from EMD
Biosciences. We purchased the following antibodies: mouse anti-
GFP monoclonal (Millipore), chicken anti-GFP polyclonal (Ab-
cam), rabbit anti-Epac2 polyclonal and mouse anti-Epac2
monoclonal (Santa Cruz), rabbit anti-HA polyclonal (Enzo) and
mouse anti-HA monoclonal (Santa Cruz), mouse anti-Ras
monoclonal (Upstate), mouse anti-Myc monoclonal (Developmen-
tal Studies Hybridoma Bank, Iowa), mouse anti-MAP2 monoclo-
nal (Millipore), and rabbit anti-Rap polyclonal antibody (Milli-
pore). A rabbit anti-GFP polyclonal antibody was a gift from Dr.
Richard Huganir (Johns Hopkins University). The pCAG-EGFP
construct was a kind gift from Atsushi Kamiya, Johns Hopkins
University. The pEGFP-N2 construct was obtained from Clon-
tech. Constructs encoding shRNA specific for Epac2 and a rescue
construct (an HA-Epac2 construct containing three silent point
mutations in the RNAi target sequence) were previously generated
and validated [22].
Neuronal Cultures and Treatments
Dissociated cultures of primary cortical neurons were prepared
from E18 Sprague-Dawley rat embryos as previously described
[22]. On DIV 21–23, neurons were transiently transfected for 4 h
with plasmids (1–3 mg DNA) using Lipofectamine 2000 (Invitro-
gen). For experiments utilizing soluble GFP, cultures were allowed
to express the transfected constructs for 2 d. For RNAi and Epac2
mutant, constructs were expressed for 5 d. Rats were used in
accordance with ACUC institutional and national guidelines
under approved protocols. Treatment of live cultured neurons was
performed in ACSF essentially as previously described [22].
Briefly, cultured neurons were transfected with GFP, and allowed
to express for 2 d. Neurons were then pre-incubated in ACSF for
1 h, imaged 2 h and 1 h before beginning of treatment, and then
imaged every hour for 6 h after beginning of treatment with either
FTaseII (200 nM) or vehicle. Coverslips were kept in culture plates
throughout the experiment, and were returned to a 37uC
incubator between imaging timepoints. Micrographs of healthy
GFP-expressing neurons with pyramidal morphologies were
acquired using a 106objective (NA=0.17) and a Zeiss AxioCam
MRm CCD camera. Dendrites were traced and binarized in
ImageJ as described below. It is of note that whereas farnesyl
transferase inhibitors were initially developed for their ability to
inhibit Ras activity, a number of other proteins are also
farnesylated, and therefore the potential contribution of other
proteins to this specific loss of basal dendrites cannot be excluded.
Visualization and Quantification of Dendritic Spine
Morphology in In Utero Electroporated Sections
For dendritic spine morphologies in vivo (Figure S2), images of
dendritic spines on biocytin-filled neurons were acquired with a
Zeiss LD Lci Plan Apochromat 256/0.8NA multi-immersion lens
(440842-9870-000000) with a digital zoom of 4. Volume imaging
was acquired with 15–35 optical sections taken in 0.75 mm focal
steps (2.13 mm axial resolution). For each condition, 5 neurons
were imaged. Two dendrites between 50 and 100 mm in length per
cell were measured: only spines on tertiary apical or secondary
basal dendrites were imaged to reduce variability. Dendritic spine
density (number of spines per 10 mm) was calculated using ImageJ.
Quantitative Immunofluorescence
Cultured pyramidal neurons were fixed, immunostained, and
imaged as previously described [22]. Protein clustering was
imaged as z-series taken at 0.37 mm intervals using a Zeiss
LSM5 Pascal confocal microscope and a 636objective (NA=1.4).
Two-dimensional maximum projection images were reconstructed
and analyzed using MetaMorph software (Molecular Devices,
Sunnyvale, CA, USA). Images were background-subtracted and
thresholded equally to include clusters with intensity at least 2-fold
above the adjacent dendrite. Regions along dendrites were
manually outlined, and the linear density (number per 100 mm
of dendrite length) and total gray value (total immunofluorescence
intensity) of each cluster was measured automatically. Cultures
that were directly compared were stained simultaneously and
imaged with the same acquisition parameters. Experiments were
carried out blind to condition and on sister cultures.
Coimmunoprecipitations
Coimmunoprecipitations (coIPs) from hEK293 cells or rat cortical
tissuewereperformedaspreviouslydescribed[22],usingRIPAbuffer
(in mM: 150 NaCl, 10 Tris-HCl, pH 7.2, 5 EDTA, 0.1% SDS, 1%
Triton X-100, 1% Deoxycholate, plus inhibitors). Precleared lysates
were incubated with 2.5–5 mL of antibody for 3 h; 60 mLo fp r o t e i n -
A Sepharose was added for 2 h at 4uC, after which samples were
washed 3 times with 0.5 ml RIPA buffer, boiled for 5 min at 95uCi n
Laemmli buffer, and analyzed by SDS-PAGE and Western blotting.
For treatment with GTPcS or GDP, cortical neurons were lysed in
Mg
2+lysis buffer containing proteaseinhibitors. Cell lysates werethen
incubated with 100 mMG T P cSo r1m MG D Pa t3 0 uCf o r3 0m i n .
Reaction was stopped by the addition of 60 mM MgCl2. Cell lysates
were harvested as described above.
In Utero Electroporation (IUEP)
C57BL6 female mice were checked for vaginal plugs (E0), and
electroporation was performed at E16.5. After proper sedation,
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PBS-wetted pads. DNA solution was loaded into beveled glass
micropipettes (100 mm oblique opening), and 0.26 ml was injected
into the lateral ventricle through the uterus wall (4 injections;
65 nL/injection) using a nanojector (Drummond Nanoject II).
DNA was electroporated into the neural precursor populations
that reside on the ventricular zone by directed electroporation, by
placing the (+) end of the electrode toward the developing
neocortex. Unipolar electric pulse of 40 V was generated (BTX
ECM830), and a total of five 50 ms pulses at an interval of 100 ms
were applied to the cerebral wall. After electroporation, embryos
were placed back into the abdominal cavity, and the rectus
abdominis and abdominal oblique muscles were sutured with 5-0
coated vicryl suture for quick absorption and fast recovery. The
skin was closed with LiquiVet tissue adhesive. Mice were allowed
to recover and give natural birth. Injected animals were collected
at P28 for further investigations. A preparation of DNA 3:1 molar
ratio was used to mix pCAG-EGFP construct [52], which
expresses EGFP under the chicken beta actin promoter, and
Epac2-RNAi cloned into pGSuper expression vector [22]. 0.05%
FastBlue was added to visualize DNA. In control experiments,
pGSuper was mixed with pCAG-eGFP construct.
Imaging of Dendrites in 50 mm IUEP Slices
Electroporated mice were anesthetized with sodium pentobar-
bital at 50 mg per gram of body weight, and fixed by transcardial
perfusion of 4% paraformaldehyde in 0.1 M sodium phosphate
buffer (pH 7.4) at P28. Brains were dissected out and sectioned
into 50 mm coronal sections and immunostained with a chicken
anti-GFP polyclonal antibody (Abcam) as floating sections, before
being mounted onto glass slides and covered with glass coverslips.
Cells exhibiting intact and healthy secondary and tertiary apical
and basal dendritic arbors were imaged by taking 1 mm serial
optical sections, 35–45 optical sections per cell, using a Zeiss
LSM5 Pascal confocal microscope and a 406objective (NA=1.3).
Following acquisition, images were projected as 2-D Z-projections
using Fiji6/ImageJ (http://imagej.nih.gov/ij/; NIH, Bethesda,
MD, USA). Dendrites were analyzed using NeuronJ plugin [53]
for Fiji6/ImageJ. Between 12 and 15 cells per condition were
analyzed.
Biocytin Filling of Paired Cells
At P28, electroporated mice were deeply anesthetized with
isoflurane and their brains were quickly removed. Brain sections
were cut at a thickness of 300 mm using an off-sagittal slice angle to
preserve apical and basal tufts of layer 2/3 cortical neurons of the
anterior frontal cortex [31]; sections were cut in ice-cold
carbogenated choline solution (in mM: 110 choline chloride, 25
NaHCO3, 2.5 KCl, 1.25 NaH2PO4, and 0.5 CaCl2, 7 MgSO4,2 5
D-glucose, 11.6 sodium ascorbate, 3.1 sodium pyruvate). Slices
were transferred to carbogenated artificial cerebrospinal fluid
(ACSF, in mM: 126 NaCl, 2.5 KCl, 26 NaHCO3, 2 CaCl2,1
MgCl2, 1.25 NaH2PO4, and 10 D-glucose) and incubated for
30 min at 35uC. They were then maintained at room temperature
for the remainder of the intracellular labeling procedure. To
maximize the amount of dendritic arbor, we selected neighboring
pairs of GFP-positive, Epac2-RNAi-expressing, and non-fluores-
cent control neurons with somata deeper than 60 mm from the
surface of the brain slice (average depth=8963.9 mm). Using a
micropipette filled with biocytin intracellular solution (in mM: 10
biocytin, 126 K-methylsulfate, 4 KCl, 10 HEPES, 4 ATP, 0.3
GTP, and 10 phosphocreatine), we dialyzed the neurons for at
least 15 min and then allowed the cells to recover for at least
30 min before fixing the slices in 4% paraformaldehyde in 0.1 M
sodium phosphate buffer (pH 7.4). Slices were then immuno-
stained with a fluorescent streptavidin-568 conjugate (Invitrogen)
and chicken anti-GFP polyclonal antibody (Abcam) as floating
sections. Sections were mounted under a #1.5 coverslip with 2 #1
coverslips (,150 mm thickness) placed either side of the section to
avoid damage to the tissue.
2-Photon Laser Scanning Microscopy (2PLSM)
Images were taken with a Prairie Ultima 2-photon in vivo
microscope, using a Mira 900F laser at a wavelength of 795 nm
(6 nm bandwidth) to locally excite both Alexa-488 and -568 nm
fluorescence, with a Zeiss LD Lci Plan Apochromat 256/0.8NA
multi-immersion lens (440842-9870-000000). Volume imaging
was acquired with 300–375 optical sections taken in 0.75 mm focal
steps (2.13 mm axial resolution). The objective lens lateral
resolution was defined to be 0.43 mm with 795 nm and
NA=0.8 and captured with pixels of 0.22 mm (2,04862,048,
440 mm field of view), 4 ms pixel dwell time. Best performance was
achieved with Cargill Type FF immersion oil, an index of 1.479,
and using the glycerol with cover slip objective lens correction
collar setting. Only pairs of cells exhibiting intact healthy
secondary and tertiary apical and basal dendrites were imaged
and used for quantification. Following acquisition, images were
projected as 2-D Z-projections using Fiji6. Dendrites were
analyzed using NeuronJ plugin for Fiji6/ImageJ. 5 animals were
analyzed.
Dendrite Visualization and Quantitative Morphometric
Analysis
To quantify dendritic morphology in vitro, cultured neurons
expressing GFP were imaged using a 106 objective (NA=0.17),
and micrographs were acquired using a Zeiss AxioCam MRm
CCD camera. Dendrites were traced and binarized in ImageJ.
The axon was identified by its distinct morphology and was
eliminated from quantification. The following criteria for identi-
fying apical and basal dendrites in cultured neurons were used.
‘‘Apical’’ dendrites were defined as the longest single protrusion,
also referred to as the primary dendrite, which has the largest
diameter proximal to the cell body [35,36], whereas ‘‘basal’’
dendrites were identified as smaller and shorter protrusions, with a
smaller diameter proximal to the cell body, compared to the
primary dendrite (Figure S3A–B). Examination of Golgi outposts
in vitro and in vivo has demonstrated that the longest dendritic
protrusions (primary dendrite) contain Golgi complexes in
cultured neurons, and that in vivo, Golgi complexes are found
in apical dendrites [34,35]. Indeed, we found that in the majority
(.90%) of neurons in our cultures, only one dendrite, typically the
longest one, was positive for giantin, a marker for the Golgi
complex (Figure S3B), which we have classified as the apical
dendrite [34]. Dendritic length was measured in MetaMorph. For
Sholl analysis, we used the Sholl analysis plugin for ImageJ
(http://biology.ucsd.edu/labs/ghosh/software) to measure the
number of dendritic processes that intersected with concentric
circles spaced 25 mm apart starting at the center of the soma. For
each parameter, 7–17 cells from 3–5 experiments were measured,
and images were acquired and quantified by an experimenter
blind to condition.
Statistical Analysis
For quantitative immunofluorescence experiments, coIPs, and
dendrite length or number measurements, differences among
condition means were identified by Student’s unpaired t tests or
ANOVAs performed in GraphPad Prism (La Jolla, CA, USA) or
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analyses were used for multiple comparisons. Error bars represent
standard errors of the mean. For Sholl analysis, mixed model
ANOVAs (condition6distance from soma) were conducted, with
distance from soma as a repeated measure. Student’s paired t tests
were used to analyze paired cell morphology.
Supporting Information
Figure S1 In utero electroporation of Epac2-RNAi reduces
basal dendrite complexity. (Related to Figure 1) (A) Schematic of
in utero microinjection and electroporation of Epac2-RNAi and
GFP cDNAs into embryonic mouse brain. cDNAs are microin-
jected into 4
th ventricle of E16.5 mouse embryos and electropo-
rated into the developing mouse neocortex. Electroporated
neurons migrate into cortex and establish connectivity with
surrounding circuits, and morphology is imaged in slices taken
at postnatal day 28. (B) Immunostaining of GFP (RNAi-positive
cells), endogenous Epac2, and DAPI in 50 mm coronal sections of
in utero electroporated brains (P28). Yellow arrows indicate
electroporated, GFP-positive, and Epac2-RNAi (Epac2-negative)
cells; white arrowheads indicate non-electroporated Epac2-posi-
tive cells. (C) Epac2 immunofluorescence intensity is decreased by
,75% in cells expressing Epac2-RNAi compared to non-
electroporated cells. ***p,0.001; scale bar, 50 mm.
(PDF)
Figure S2 Epac2 regulates higher order basal dendrite com-
plexity, without affecting apical dendrite complexity in vivo.
(Related to Figure 2) (A–B) Quantification of total apical and basal
dendrite number (A) and length (B) in paired cells; blue square,
control; red circles, Epac2-RNAi; black squares with error bars,
mean, SEM. (C) Quantification of apical dendrite numbers,
separated into primary, secondary, or tertiary and above, reveals
no effect of Epac2 knockdown in vivo on apical dendrite number
compared to paired control; blue square, control; red circles,
Epac2-RNAi; black squares with error bars, mean, SEM. (D)
Analysis of apical dendrites, separated into primary, secondary, or
tertiary and above, demonstrates no effect of Epac2 knockdown on
apical dendrite length. (E) Representative images of dendritic
spines in tertiary apical or secondary basal dendrites in control or
Epac2-RNAi-expressing layer 2/3 cortical neurons. (F) Quantifi-
cation of dendritic spine number in tertiary apical or secondary
basal dendrites in control or Epac2-RNAi-expressing layer 2/3
cortical neurons. Long-term expression of Epac2-RNAi signifi-
cantly reduces dendritic spine number in apical and basal
dendrites. (G) Epac2-RNAi reduces dendritic spine density on
both apical and basal dendrites with pairs of electroporated
neurons. *p,0.05, **p,0.01; scale bar, 5 mm.
(PDF)
Figure S3 Quantification of dendritic complexity and length.
(Related to Figure 3) (A) Representative image of primary,
classified as apical (black) and non-primary, classified as basal
(red) dendrites of cortical pyramidal neurons (DIV 25). (B) Double
immunostaining with MAP2 and Golgi complex marker, giantin.
Primary (apical) dendrite is identified by red arrow. Note the
presence of Golgi in the apical dendrite, as well as differences
between apical and basal dendrite diameters. (C) Schematic of
Sholl analysis of basal and apical dendrites separately. (D)
Schematic of how dendrite length measurements were performed.
Each dendrite was traced (red dotted line represents tracing of
apical dendrites, whereas black dotted line represents tracing of
basal dendrites), and total dendritic length of each compartment
was calculated. (E) Quantification of Epac2 expression levels in
apical or basal dendrites in either control (pGSuper) or Epac2-
RNAi-expressing cells. In both compartments, Epac2 is knocked
down with equal efficiency (,75%). ***p,0.001.
(PDF)
Figure S4 Epac2-G706R overexpression impairs basal dendrite
maintenance and interaction with Ras. (Related to Figure 4) (A)
Representative binary traces of cortical neurons expressing GFP or
GFP+Epac2-G706R. (B) Sholl analysis reveals that complexity of
the basal dendrite arbor was reduced in cells expressing Epac2-
G706R compared to cells expressing GFP. (C) Quantification of
apical and basal dendrite length reveals no difference in dendritic
length of basal arbors. (D) Epac2 and Ras coimmunoprecipitate in
hEK293 cells. HA-tagged Epac2-WT and YFP-tagged Ras were
expressed in hEK293 cells, and immunoprecipitated using a rabbit
anti-GFP polyclonal antibody. ***p,0.001; scale bar, 100 mm.
(PDF)
Figure S5 Inhibition of Ras activity reduces basal dendritic
maintenance. (Related to Figure 5) (A) Binary images of full
dendritic arbors of cortical neurons shown in Figure 5A (dashed red
rectangle indicates basal arbor shown in Figure 5A) at 22h r
pretreatment. Neurons were imaged live and treated with vehicle or
farnesyltransferaseinhibitorII(FTaseII,200 nM)for6 h.(B)Binary
images of cortical neurons treated with FTaseII (200 nM) or vehicle
for 6 h, and subsequently fixed and imaged. (C) Sholl analysis of
apical and basal dendrites reveals that FTaseII treatment for 6 h
selectively reduces complexity of basal arbors. (D) Quantification of
mean dendritic length for apical dendrites and basal dendrites
demonstrates a reduction of basal dendrite length induced by
FTaseII treatment. (E) Representative binary images of cortical
neurons expressing GFP, GFP+RasDN, or GFP+RasDN+Epac2-
WT. (F) Sholl analysis of apical and basal dendrites reveals a
significant decrease in basal complexity in RasDN-expressing cells;
this effect is rescued by Epac2-WT overexpression. (G) Quantifi-
cation of apical and basal dendrite length. *p,0.05, **p,0.01,
***p,0.001; scale bars, 100 mm (A, B, E).
(PDF)
Figure S6 Asymmetric distribution of ectopically expressed
Epac2-WT and Epac2-G706R, but lack of asymmetric distribu-
tion of kalirin-7 and p-PAK in cortical neuron dendrites. (Related
to Figure 6) (A) Distribution of HA-Epac2-WT in apical and basal
dendrites. Exogenous mCherry indicates dendrites. HA-Epac2-
WT fluorescence intensity (normalized to unit area, mm
2, and
indicated by pseudocoloring) is reduced in secondary basal
dendrites. (B) Distribution of HA-Epac2-G706R in apical and
basal dendrites. Exogenous mCherry indicates dendrites. HA-
Epac2-G706R fluorescence intensity (normalized to unit area,
mm
2, and indicated by pseudocoloring) is reduced in secondary
basal dendrites. (C) Comparison of Epac2 immunofluorescence
levels in (A–B) normalized to Epac2-WT apical levels reveals a
significant decrease in basal Epac2-G706R intensity compared to
basal Epac2-WT intensity. (D) Distribution of the Rac-GEF
kalirin-7 over apical and basal dendrites. Yellow dashed boxes
indicate areas in high magnification to the right. Overexpressed
GFP was used to outline dendrite morphology. Intensity of kalirin-
7 staining was normalized to unit area (mm
2) over a 50 mm length
of secondary apical or basal dendrite to account for thickness of
dendrite. Kalirin-7 fluorescence intensity is equally abundant in
basal and apical dendrites. (E) Examination of p-PAK (an
indicator of Rac signaling): immunostaining revealed that p-
PAK fluorescence intensity is equally abundant in basal and apical
dendrites. Endogenous MAP2 was used to indicate dendrites.
Scale bars, 35 mm (A, B, D, E), 5 mm (A, B, D, E insets).
(PDF)
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PLoS Biology | www.plosbiology.org 15 June 2012 | Volume 10 | Issue 6 | e1001350Figure S7 Asymmetric distribution and regulation of p-BRaf in
cortical neuron dendrites. (Related to Figure 7) (A) Staining of
endogenous p-BRaf in apical and basal secondary dendrites
treated with vehicle or FTaseII. Images are high magnifications of
areas in yellow dashed boxes indicated in Figure 7A. Inhibition of
Ras signaling by FTaseII (30 min, 200 nM) reduced p-BRaf
immunofluorescence in basal dendrites compared to apical
dendrites. Endogenous MAP2 was used to indicate dendrites. (B)
Quantification of p-BRaf immunofluorescence in basal versus
apical dendrites following FTaseII treatment; p-BRaf fluorescence
intensity was normalized to unit area, mm
2. (C) Comparison of p-
BRaf immunofluorescence in basal versus apical dendrites after
30 min FTaseII treatment relative to control apical levels (dashed
gray line). (D) Quantification of Epac2 distribution in secondary
apical or basal dendrites from cells expressing pGSuper (control
RNAi) or Epac2-RNAi; Epac2 intensity was normalized to unit
area, mm
2. Epac2 is asymmetrically distributed with less expression
in basal dendrites compared to apical dendrites in both control
and Epac2-RNAi expressing cells. (E) Comparison of endogenous
Epac2 fluorescence intensities in (D), normalized to control apical
levels, reveals a significant decrease in Epac2 levels in control basal
dendrites, but no significant difference in Epac2 levels in Epac2-
RNAi apical dendrites versus control basal dendrites. (F) Staining
of endogenous p-BRaf in apical and basal dendrites in the
presence of pGSuper or Epac2-RNAi. Images are high magnifi-
cations of areas in yellow dashed boxes indicated in Figure 7D.
Inhibition of Epac2 function by Epac2-RNAi resulted in selective
and robust reduction of p-BRaf immunofluorescence in basal
dendrites compared to apical dendrites. Overexpressed GFP was
used to outline dendrite morphology. (G) Quantification of p-BRaf
immunofluorescence in basal versus apical dendrites in Epac2-
RNAi-expressing cells; p-BRaf fluorescence intensity was normal-
ized to unit area, mm
2. (H) Comparison of p-BRaf immunofluo-
rescence in basal versus apical dendrites in Epac2-RNAi-
expressing cells relative to control (pGSuper) apical levels (dashed
gray line). *p,0.05, **p,0.01, # ***p,0.001; #, compared to
control apical (C, E, H). scale bars, 5 mm (A, F).
(PDF)
Table S1 Quantification of dendritic morphology for apical and
basal dendritic branch number and length in in utero electropo-
rated 50 mm sections.
(PDF)
Table S2 Quantification of apical and basal dendritic branch
number in in utero electroporated paired neurons in 300 mm
sections.
(PDF)
Table S3 Quantification of apical and basal dendritic branch
length in in utero electroporated paired neurons in 300 mm
sections.
(PDF)
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